• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

ATPases as drug targets: learning from their structure - pp665 - 673

Patrick Chène

doi:10.1038/nrd894

• Abstract
• Full Text
• PDF (743 KB)

Phosphodiesterase 5 inhibitors: current status and potential applications - pp674 - 682

David P. Rotella

doi:10.1038/nrd893

• Abstract
• Full Text
• PDF (260 KB)

Clinical proteomics: translating benchside promise into bedside reality - pp683 - 695

Emanuel F. Petricoin, Kathryn C. Zoon, Elise C. Kohn, J. Carl Barrett & Lance A. Liotta

doi:10.1038/nrd891

• Abstract
• Full Text
• PDF (1,136 KB)

Protein tyrosine phosphatase 1B inhibitors for diabetes - pp696 - 709

Theodore O. Johnson, Jacques Ermolieff & Michael R. Jirousek

doi:10.1038/nrd895

• Abstract
• Full Text
• PDF (879 KB)

Pharmacotherapy of addictions - pp710 - 726

Mary Jeanne Kreek, K. Steven LaForge & Eduardo Butelman

doi:10.1038/nrd897

• Abstract
• Full Text
• PDF (552 KB)
• Supplementary information